Cellertz
- Biotech or pharma, therapeutic R&D
Cellertz Bio is a mRNA therapeutics company combining cutting-edge artificial intelligence and physics-based models to unlock the full potential of mRNA medicines. Our proprietary platform, Codonscope, systematically explores the vast mRNA sequence space to design optimized mRNA molecules with superior stability, translation efficiency, and protein expression—enabling a new generation of high-performance mRNA therapies. Built on Codonscope, Cellertz is developing a proprietary therapeutic pipeline focused on in vivo immune cell engineering to treat cancer and autoimmune diseases. These R&D programs offer scalable, off-the-shelf alternatives to currently available cell therapies.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}